SCHEMBL7678122

SCHEMBL7678122

O=C(CC(=O)Oc1cc(Cl)ccc1[N+](=O)[O-])Oc1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
BACE1 P56817 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
PKM P14618 1/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
HPGD P15428 2/20 0.45
CYP2C19 P33261 2/20 0.45
MAPT P10636 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678123 0.93 MAPK1 (0.46) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL7678134 0.93 MAPK1 (0.46) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL27559947 0.88 L3MBTL1 (0.48) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL7683695 0.88 KDM4E (0.52) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL21580836 0.83 TSHR (0.51) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL9597051 0.83 TSHR (0.51) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL29848653 0.82 SMN1; SMN2 (0.44) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21580855 0.82 TSHR (0.47) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL26961596 0.81 MAPK1 (0.45) MAPK1L3MBTL1ALDH1A1PKMMAPT
SCHEMBL28107031 0.81 TSHR (0.41) TSHRMAPK1L3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013093928-A1 AN IMPROVED PROCESS FOR PREPARING 2-OXINDOLES OF FORMULA I, A KEY RAW MATERIAL FOR MAKING PHARMACEUTICAL DRUGS AND INTERMEDIATES THEREOF ARCH PHARMALABS LIMITED (IN) 2013-06-27 WO disclosed
US-6469181-B1 PREPARING 2-OXINDOLES AND N-HYROXY-2- OXINDOLES VIA REDUCTION OF 2-NITROARYLMALONATE DIESTERS WITHOUT ISOLATION OF INTERMEDIATES CATALYTICA, INC. 2002-10-22 US disclosed